Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st December 2025
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 9.0% | 5.9% | 23.4% |
| 2025 |
|---|
| 23.4% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 9.0% | 5.9% | 23.4% |
| 2025 |
|---|
| 23.4% |
The Brandes Small Cap Value Fund delivered strong quarterly performance, returning 5.88% versus 2.19% for the Russell 2000 Index, driven primarily by holdings in industrials including machinery companies Kennametal and Graham Corporation, and aerospace businesses Moog and Hexcel. Other contributors included Sealed Air, Innovex International, and Avadel Pharmaceuticals, which was sold after reaching intrinsic value amid a bidding war between Alkermes and H. Lundbeck. Healthcare underweighting and declines in Utah Medical Products and Grifols detracted from performance, along with weakness in Edgewell Personal Care, Arlo Technologies, and Netgear. The fund added Central Garden & Pet Company, viewing the pet and garden distributor as attractively valued despite near-term headwinds from demand normalization and overseas competition. The portfolio maintains overweight positions in industrials while underweighting financials and real estate. Management expresses optimism about value stocks and believes the fund remains well-positioned for long-term risk-adjusted returns given its focus on companies with strong fundamentals and lower valuations than the broader small-cap market.
The Brandes Small Cap Value Fund seeks to capitalize on undervalued small-cap companies with strong balance sheets, compelling growth prospects, and durable free cash flow generation, maintaining differentiated sector positioning compared to broader small-cap benchmarks.
We are optimistic about the potential of value stocks in general and believe the Brandes Small Cap Value Fund remains well positioned from a long-term risk/reward perspective.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Jan 23 2026 | 2025 Q4 | ALKS, AOBC, ARLO, AVDL, CENT, DIIBF, ELAN, EPC, GHM, GIL, GRFS, HURC, HXL, IMKTA, INVX, KMT, MOG.A, NTGR, ORN, PKE, PZZA, RGP, SEE, UTMD | healthcare, industrials, Outperformance, positioning, small caps, value | CENT | The fund focuses on small-cap value investing, seeking companies with strong balance sheets, compelling growth prospects, and durable free cash flow generation. The fund exhibits… |
| Oct 21 2025 | 2025 Q3 | GLOB, PBH | digital transformation, Health Care, industrials, small caps, value |
GLOB PBH GLOB PBH |
Small-cap value stocks advanced strongly, led by health care and industrial holdings like Elanco and Park Aerospace. Managers added to undervalued names such as Prestige… |
| Jul 22 2025 | 2025 Q2 | GHM, HCSG, ORN, OTEX CN | fundamentals, small caps, undercoverage, valuation, volatility | - | The fund discusses small-cap stocks as fertile ground for value creation amid limited coverage and forced selling. Management emphasizes balance sheet strength and normalized earnings.… |
| Mar 31 2025 | 2025 Q1 | ERJ, LNSR, ORN, PZZA | - | - | - |
| Dec 31 2024 | 2024 Q4 | - | - | - | - |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2025 Q4 |
Small CapsThe fund invests in a portfolio of competitively advantaged small and medium-sized businesses, which remained out of favor for most of the quarter. The strategy of owning leading small-cap businesses has been the foundation since inception, delivering 354 basis points of annual outperformance over the benchmark since inception despite recent headwinds. |
Growth Outperformance Benchmark Russell Businesses |
ValueManager emphasizes investing in controlled companies trading at significant discounts to NAV, with European holding companies showing discounts of 30-68%. The strategy focuses on securities mispricing where real value exists, contrasting with overvalued technology stocks. |
Discounts NAV Mispricing Undervalued Controlled | |
| 2025 Q3 |
HealthcareHealthcare was the strongest relative contributor in the quarter with holdings increasing nearly +16% compared to benchmark returns of roughly +12%. Exact Sciences was acquired for a significant premium by Abbott Laboratories resulting in an +86% return, while other strong performers included Tarsus Pharmaceuticals, Glaukos following approval of a new product, Penumbra, and Repligen driven by strong earnings results. |
M&A Product Approval Earnings Biotech |
IndustrialsThe fund increased exposure to high-quality industrial businesses with potential for cyclical upturn. Added Quanta Services for AI data center build-out, Hubbell for electrical grid upgrades, Old Dominion for freight cycle recovery, and Waste Connections for secondary market focus. |
Infrastructure Automation Transportation Electrical Equipment Waste Management | |
Small CapsThe fund invests in a portfolio of competitively advantaged small and medium-sized businesses, which remained out of favor for most of the quarter. The strategy of owning leading small-cap businesses has been the foundation since inception, delivering 354 basis points of annual outperformance over the benchmark since inception despite recent headwinds. |
Growth Outperformance Benchmark Russell Businesses | |
| 2025 Q2 |
SmallCap |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 2025 | Fund Letters | Bryan Barrett | GLOB | Globant S.A. | Information Technology | IT Services | Bull | NYSE | AI, Consulting, Digital transformation, growth, IT services, recovery, valuation | Login |
| Oct 21, 2025 | Fund Letters | Bryan Barrett | PBH | Prestige Consumer Healthcare | Health Care | Pharmaceuticals | Bull | NYSE | Acquisitions, brands, cashflow, consumer, healthcare, OTC, pharmaceuticals | Login |
| Oct 21, 2025 | Fund Letters | Bryan Barrett | GLOB | Globant S.A. | Information Technology | IT Services | Bull | NYSE | AI, Consulting, Digital transformation, growth, IT services, recovery, valuation | Login |
| Oct 21, 2025 | Fund Letters | Bryan Barrett | PBH | Prestige Consumer Healthcare | Health Care | Pharmaceuticals | Bull | NYSE | Acquisitions, brands, cashflow, consumer, healthcare, OTC, pharmaceuticals | Login |
| Jan 23, 2026 | Fund Letters | Bryan Barrett | CENT | Central Garden & Pet Company | Consumer Staples | Household Products | Bull | NASDAQ | Acquisitions, Costreduction, Gardening, Margins, Pets | Login |
| TICKER | COMMENTARY |
|---|---|
| ARLO | Other detractors included Edgewell Personal Care, security systems company Arlo Technologies. Meanwhile, Arlo was met with unease about its declining year-over-year free cash flow margin. |
| AVDL | In October, Avadel announced it would be acquired by Alkermes for a total value of $2.1 billion with the full value subject to FDA approval of Lumryz for treating idiopathic hypersomnia in adults by the end of 2028. The following month, H. Lundbeck made an unsolicited proposal valuing Avadel at about $2.4 billion, prompting Alkermes to raise its offer. Amid the bidding war, Avadel's share price reached our estimate of its intrinsic value, leading us to divest the Fund's position. |
| CENT | The small-cap investment committee bought Central Garden & Pet Company (CENT) while selling Pediatrix Medical Group and Avadel Pharmaceuticals. Central Garden & Pet is a leading U.S. distributor and manufacturer in the lawn, garden, and pet supply industries. Founded in 1980, it initially focused on distributing lawn and garden products, later expanding through acquisitions to include pet supplies. During the past 30 years, CENT has completed 60 acquisitions and evolved into a market leader, manufacturing both branded and private label products for national retailers. Slowing revenue growth from post-pandemic demand normalization, increased competition from low-cost overseas suppliers and shifting consumer spending habits have weighed on CENT's share price, creating an attractive investment opportunity at current levels. |
| EPC | Other detractors included Edgewell Personal Care |
| GHM | Leading contributors included holdings in the industrials sector, led by machinery companies Kennametal and Graham Corporation |
| GRFS | Further, select holdings in the sector declined, namely Utah Medical Products and Grifols |
| HURC | Hurco is a small industrial company. It makes computer numerical controlled (CNC) machines. I've owned Hurco in the past. It's a fairly illiquid stock. The company depends on a cyclical industrial sector improvement. I don't have a strong opinion on if/when that happens. I do have an opinion that the company trades at half its book value, meaning if it can sell its on the books inventory of machines for close to full price, it will be worth much more as a stock. |
| HXL | Leading contributors included holdings in the industrials sector, led by machinery companies Kennametal and Graham Corporation, as well as aerospace and defense businesses Moog and Hexcel |
| INVX | Other strong performers included containers and packaging business Sealed Air, energy equipment and services business Innovex International |
| KMT | Leading contributors included holdings in the industrials sector, led by machinery companies Kennametal |
| MOG.A | Leading contributors included holdings in the industrials sector, led by machinery companies Kennametal and Graham Corporation, as well as aerospace and defense businesses Moog |
| NTGR | Other detractors included Edgewell Personal Care, security systems company Arlo Technologies, communications equipment business Netgear. Netgear's decline was primarily due to concerns over supply chain issues, rising memory costs, and a mixed outlook from management during its third quarter earnings call. |
| ORN | Some of our technology and industrial-themed holdings such as Orion Group continued to produce meaningful contributions |
| PZZA | Other detractors included Edgewell Personal Care, security systems company Arlo Technologies, communications equipment business Netgear and pizza restaurant chain Papa John's International |
| SEE | Other strong performers included containers and packaging business Sealed Air |
| UTMD | Further, select holdings in the sector declined, namely Utah Medical Products |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||